“…The effective delivery of stem cells or osteogenic cells derived from bone marrow or other source organs has been investigated in the context of tissue engineering and regeneration [ 12 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 ]. Various methods to improve cellular delivery have also been examined, including cell sheet technology, injectable vehicles, carrier molecules, and 3-dimensional (3D) cell printing [ 2 , 27 , 29 , 46 , 47 , 48 , 49 , 50 , 51 , 52 ]. Despite some progress, cell-based repair and regeneration of tissues, particularly fractured and diseased bone remains far from being a standard clinical modality, with the approach hampered by poor clinical viability, high costs, and suboptimal biological efficacy [ 37 , 38 , 47 , 53 , 54 , 55 , 56 , 57 , 58 , 59 ].…”